Capital International Investors Sarepta Therapeutics, Inc. Transaction History
Capital International Investors
- $504 Billion
- Q3 2024
A detailed history of Capital International Investors transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Capital International Investors holds 6,259,282 shares of SRPT stock, worth $718 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
6,259,282
Previous 4,320,827
44.86%
Holding current value
$718 Million
Previous $683 Million
14.52%
% of portfolio
0.16%
Previous 0.14%
Shares
9 transactions
Others Institutions Holding SRPT
# of Institutions
530Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.18 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.03 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$500 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$490 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.73MShares$313 Million0.06% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...